Target intelligence / Profile preview

Novel transcript, antisense to APBA3

Molecular classification
Long non-coding RNA (lncRNA), antisense RNA
01

Overview

This entry corresponds to a long non-coding RNA transcript produced from the strand opposite APBA3, encoding no protein. Such natural antisense transcripts (NATs) are widespread in the human genome and may regulate the expression of their sense counterparts through a variety of mechanisms (e.g., transcriptional interference, RNA masking, RNAi, or chromatin modification). While some NATs have notable biological or disease roles, there is no evidence this specific transcript is a protein or a validated therapeutic target, nor is there information on direct drug interactions, biomarker use, or safety profile.

02

Biological functions

Potential regulation of APBA3 gene expression (regulation by antisense lncRNAs may include transcriptional interference, RNA masking, RNA interference, or chromatin remodeling)
03

Disease associations

Other (lncRNA NATs can play roles in diverse disease mechanisms, but there is no specific disease link established for this particular transcript)

Beyond the preview

Go deeper on Novel transcript, antisense to APBA3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to APBA3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call